160 related articles for article (PubMed ID: 38030868)
1. Preferences and Willingness to Pay for Medication in Patients with Renal Cell Carcinoma in China: A Discrete-Choice Experiment.
Ding R; Shao R; Zhang L; Yan J
Patient; 2024 Jan; 17(1):97-108. PubMed ID: 38030868
[TBL] [Abstract][Full Text] [Related]
2. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
Front Public Health; 2021; 9():653450. PubMed ID: 33842426
[No Abstract] [Full Text] [Related]
3. Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma.
Wong MK; Mohamed AF; Hauber AB; Yang JC; Liu Z; Rogerio J; Garay CA
J Med Econ; 2012; 15(6):1139-48. PubMed ID: 22808923
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
Chuang LH; Zhang H; Hong T; Xie S
Patient; 2024 Apr; ():. PubMed ID: 38642244
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
González JM; Doan J; Gebben DJ; Boeri M; Fishman M
Pharmacoeconomics; 2018 Aug; 36(8):973-986. PubMed ID: 29869777
[TBL] [Abstract][Full Text] [Related]
6. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment.
Zhao J; Wang H; Li X; Hu Y; Yan VKC; Wong CKH; Guo Y; Cheung MKH; Lip GYH; Siu CW; Tse HF; Chan EW
PLoS Med; 2021 Aug; 18(8):e1003730. PubMed ID: 34437553
[TBL] [Abstract][Full Text] [Related]
7. The effect of information on preferences for treatments of metastatic renal cell carcinoma.
Mansfield C; Srinivas S; Chen C; Hauber AB; Hariharan S; Matczak E; Sandin R
Curr Med Res Opin; 2016 Nov; 32(11):1827-1838. PubMed ID: 27404275
[TBL] [Abstract][Full Text] [Related]
8. Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment.
Gawronski BE; Salloum RG; Duarte JD
Front Pharmacol; 2024; 15():1384667. PubMed ID: 38595920
[No Abstract] [Full Text] [Related]
9. Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma.
Mohamed AF; Hauber AB; Neary MP
Pharmacoeconomics; 2011 Nov; 29(11):977-88. PubMed ID: 21854079
[TBL] [Abstract][Full Text] [Related]
10. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
11. What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.
Keller E; Botha W; Chambers GM
Appl Health Econ Health Policy; 2023 Jan; 21(1):91-107. PubMed ID: 36171511
[TBL] [Abstract][Full Text] [Related]
12. Patient Preferences For Chemotherapy In The Treatment Of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study In China.
Sun H; Wang H; Xu N; Li J; Shi J; Zhou N; Ni M; Hu X; Chen Y
Patient Prefer Adherence; 2019; 13():1701-1709. PubMed ID: 31631985
[TBL] [Abstract][Full Text] [Related]
13. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
[TBL] [Abstract][Full Text] [Related]
14. Understanding influencing attributes of COVID-19 vaccine preference and willingness-to-pay among Chinese and American middle-aged and elderly adults: A discrete choice experiment and propensity score matching study.
Li X; Yang L; Tian G; Feng B; Jia X; He Z; Liu T; Zhao X; Huang M; Yu W; Yu L; Ming WK
Front Public Health; 2023; 11():1067218. PubMed ID: 37006586
[TBL] [Abstract][Full Text] [Related]
15. Patients' preferences and willingness-to-pay for disease-modifying therapies.
Frost N; Freeman J; Brixner D; Mort J; Clem J; Ngorsuraches S
Mult Scler Relat Disord; 2019 Oct; 35():55-60. PubMed ID: 31323483
[TBL] [Abstract][Full Text] [Related]
16. Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.
Si L; Tu L; Xie Y; Palmer AJ; Gu Y; Zheng X; Li J; Lv Q; Qi J; Lin Z; Chen M; Gu J; Hiligsmann M
Arch Osteoporos; 2019 Jul; 14(1):85. PubMed ID: 31367860
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
[TBL] [Abstract][Full Text] [Related]
18. Public preferences for online medical consultations in China: a discrete choice experiment.
Wang P; Huang Y; Li H; Xi X
Front Public Health; 2023; 11():1282387. PubMed ID: 38192546
[TBL] [Abstract][Full Text] [Related]
19. Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists.
Fernández O; Lázaro-Quintela M; Crespo G; Soto de Prado D; Pinto Á; Basterretxea L; Gómez de Liaño A; Etxaniz O; Blasco S; Gabás-Rivera C; Aceituno S; Palomar V; Polanco-Sánchez C
Front Oncol; 2021; 11():773366. PubMed ID: 35070976
[TBL] [Abstract][Full Text] [Related]
20. Valuing the delivery of dental care: Heterogeneity in patients' preferences and willingness-to-pay for dental care attributes.
Sever I; Verbič M; Sever EK
J Dent; 2018 Feb; 69():93-101. PubMed ID: 29242040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
